Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer - Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial.
Fink CA, Ristau J, Buchele C, Klüter S, Liermann J, Hoegen-Saßmannshausen P, Sandrini E, Lentz-Hommertgen A, Baumann L, Andratschke N, Baumgartl M, Li M, Reiner M, Corradini S, Hörner-Rieber J, Bonekamp D, Schlemmer HP, Belka C, Guckenberger M, Debus J, Koerber SA.
Fink CA, et al. Among authors: buchele c.
Clin Transl Radiat Oncol. 2024 Mar 25;46:100771. doi: 10.1016/j.ctro.2024.100771. eCollection 2024 May.
Clin Transl Radiat Oncol. 2024.
PMID: 38586081
Free PMC article.